Abstract
Recently a possible cross talk about the relationship between p53 and beta-catenin has been suggested by the observation that colorectal cancers accumulating beta-catenin (as a result of APC mutations) also exhibit high frequency p53 mutations. Our aim was to evaluate the pattern of both the proteins and match these with the morphological changes in colorectal carcinogenesis. Immunohistochemical patterns of p53 and beta catenin were studied using the natural carcinogenetic model of malignant colorectal sporadic adenoma in 27 formalin-fixed paraffinembedded polyps. We found a progressive increase of p53 and beta-catenin staining from normal, to dysplastic, and to cancerous epithelium. We noted, in dysplastic and cancerous epithelium, but not in normal tissue, the translocation of beta-catenin from the cytoplasm to the nucleus, and in dysplastic epithelium, a significant correlation between p53 over expression and betacatenin patterns. Beta-catenin cytoplasmic accumulation seemed to drive p53 over expression already in the early stages of carcinogenesis, while nuclear beta-catenin translocation appeared to be related to a pattern of invasion of neoplastic cells.
Keywords: colorectal adenoma, immunohistochemistry, p53, beta-catenin
Current Pharmaceutical Design
Title: P53 and Beta-Catenin in Colorectal Cancer Progression
Volume: 9 Issue: 24
Author(s): Anna Maria Valentini, Michele Pirrelli, Letizia Renna, Raffaele Armentano and Maria Lucia Caruso
Affiliation:
Keywords: colorectal adenoma, immunohistochemistry, p53, beta-catenin
Abstract: Recently a possible cross talk about the relationship between p53 and beta-catenin has been suggested by the observation that colorectal cancers accumulating beta-catenin (as a result of APC mutations) also exhibit high frequency p53 mutations. Our aim was to evaluate the pattern of both the proteins and match these with the morphological changes in colorectal carcinogenesis. Immunohistochemical patterns of p53 and beta catenin were studied using the natural carcinogenetic model of malignant colorectal sporadic adenoma in 27 formalin-fixed paraffinembedded polyps. We found a progressive increase of p53 and beta-catenin staining from normal, to dysplastic, and to cancerous epithelium. We noted, in dysplastic and cancerous epithelium, but not in normal tissue, the translocation of beta-catenin from the cytoplasm to the nucleus, and in dysplastic epithelium, a significant correlation between p53 over expression and betacatenin patterns. Beta-catenin cytoplasmic accumulation seemed to drive p53 over expression already in the early stages of carcinogenesis, while nuclear beta-catenin translocation appeared to be related to a pattern of invasion of neoplastic cells.
Export Options
About this article
Cite this article as:
Valentini Maria Anna, Pirrelli Michele, Renna Letizia, Armentano Raffaele and Caruso Lucia Maria, P53 and Beta-Catenin in Colorectal Cancer Progression, Current Pharmaceutical Design 2003; 9 (24) . https://dx.doi.org/10.2174/1381612033454216
DOI https://dx.doi.org/10.2174/1381612033454216 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Agents Targeting Ras Signaling Pathway
Current Pharmaceutical Design Potential Application of Gene Therapy to X-Linked Agammaglobulinemia
Current Gene Therapy Meaning Centered Psychotherapy: The State of the Art
Current Psychiatry Reviews 4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases
Current Medicinal Chemistry Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability
Current Drug Delivery Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Intractable Cancers: The Many Faces of Multidrug Resistance and the Many Targets it Presents for Therapeutic Attack
Current Drug Targets Expression Profile of Genes Associated with the Proteins Degradation Pathways in Colorectal adenocarcinoma
Current Pharmaceutical Biotechnology Hydroxychloroquine (HCQ) and its Synthetic Precursors: A Review
Mini-Reviews in Organic Chemistry Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Current Cancer Drug Targets A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology A Constrained Probabilistic Matrix Decomposition Method for Predicting miRNA-disease Associations
Current Bioinformatics New Concepts for Glaucoma Implants - Controlled Aqueous Humor Drainage, Encapsulation Prevention and Local Drug Delivery
Current Pharmaceutical Biotechnology Cytokine Antibody Arrays in Biomarker Discovery and Validation
Current Proteomics Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models
CNS & Neurological Disorders - Drug Targets Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer
Current Pharmaceutical Biotechnology